354
Participants
Start Date
December 31, 2002
Study Completion Date
December 31, 2007
oregovomab
St. Vincent's Comprehensive Cancer Center, New York
Nyack Hospital, Nyack
North Shore University Hospital, Manhasset
SUNY-HSC Syracuse, Crouse Hospital, Syracuse
University of Virginia Cancer Center, Charlottesville
VA Oncology Associates, Norfolk
Carilion GYN Oncology Associates, Roanoke
Duke University Medical Center, Durham
Blumenthal Cancer Center, Charlotte
South Carolina Oncology Associates, Columbia
Gynecologic Oncology Research and Development, Greenville
Medical College of Georgia, Augusta
Pensacola Research Consultants, Pensacola
Florida Hospital Cancer Institute, Orlando
Florida Gynecologic Oncology, Fort Myers
Comprehensive Cancer Institute, Huntsville
Chattanooga GYN Oncology, Chattanooga
West Clinic, PC, Memphis
Women's Specialty Center, Jackson
Brown Cancer Center, Louisville
Louisville Oncology, Louisville
GYN Oncology and Pelvic Surgery Associates, Columbus
ProMedica Health Systems, Toledo
University Hospital - Health Systems, Cleveland
St. Vincent Gynecologic Oncology, Indianapolis
Michiana Hematology Oncology PC, South Bend
The University of Chicago Hospitals, Chicago
Ellis Fischel Cancer Center, Columbia
Hematology and Oncology Specialists, New Orleans
Lake Charles Medical Surgical Clinic, Lake Charles
Little Rock Hematology Oncology Assoc., Little Rock
Oklahoma University Health Sciences Center, Oklahoma City
Arlington Cancer Center, Arlington
Texas Oncology, Fort Worth
The Center for Cancer and Blood Disorders, Fort Worth
Southwest Regional Cancer Center, Austin
Rocky Mountain Cancer Center-Midtown, Denver
Utah Cancer Specialists, Salt Lake City
Western Regional Community Clinical Oncology Program, Phoenix
Cedars-Sinai Medical Center, Los Angeles
Wilshire Oncology Medical Group, La Verne
Sharp Memorial Hospital, San Diego
Gynecologic Oncology Associates, Newport Beach
St. Jude Medical Center, Fullerton
University of California, Irvine, Orange
Stanford University, Stanford
Northwest Cancer Specialists-Northrup, Portland
Swedish Medical Center, Seattle
Northwest Cancer Specialists-Vancouver, Vancouver
Cancer Care Northwest, Spokane
UCLA School of Medicine, Los Angeles
University of Connecticut Cancer Center, Farmington
Northwestern Connecticut Oncology Hematology Associates, LLP, Torrington
H. Lee Moffitt Cancer Center and Research, Tampa
The Harry and Jeanette Weinberg Cancer Institute, Baltimore
New England Medical Center, Boston
Jersey Shore Medical Center, Neptune City
Medical College of Ohio Cancer Institute, Toledo
Magee-Womens Hospital, Pittsburgh
Brown University School of Medicine, Providence
Univ. of Texas SW Medical Center at Dallas, Dallas
Texas Oncology, PA, Dallas
Lead Sponsor
Unither Pharmaceuticals
INDUSTRY